Targeting of drugs and nanoparticles to tumors
The various types of cells that comprise the tumor mass all carry molecular markers that are not expressed or are expressed at much lower levels in normal cells. These differentially expressed molecules can be used as docking sites to concentrate drug conjugates and nanoparticles at tumors. Specific...
Main Authors: | Ruoslahti, Erkki (Author), Sailor, Michael J. (Author), Bhatia, Sangeeta N. (Contributor) |
---|---|
Other Authors: | Whitaker College of Health Sciences and Technology (Contributor), Massachusetts Institute of Technology. Department of Electrical Engineering and Computer Science (Contributor) |
Format: | Article |
Language: | English |
Published: |
Rockefeller University Press,
2010-09-24T14:59:44Z.
|
Subjects: | |
Online Access: | Get fulltext |
Similar Items
-
Targeting of drugs and nanoparticles to tumors
by: Rusolahti, Erkki, et al.
Published: (2011) -
Cooperative nanoparticles for tumor detection and photothermally triggered drug delivery
by: Park, Ji-Ho, et al.
Published: (2012) -
Fusogenic porous silicon nanoparticles as a broad-spectrum immunotherapy against bacterial infections
by: Kim, Byungji, et al.
Published: (2022) -
Nanoparticles that communicate in vivo to amplify tumour targeting
by: Park, Ji-Ho, et al.
Published: (2012) -
Nanoparticle amplification via photothermal unveiling of cryptic collagen binding sites
by: Lo, Justin H., et al.
Published: (2013)